Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: technical aspects and primary staging setting

Abstract Background Prostate-specific membrane antigen PET/CT (PSMA PET/CT) has become a cornerstone in the imaging of prostate cancer (PCa), supported by growing evidence and international guideline endorsements. However, real-world adoption and clinical integration of PSMA PET/CT in Italy remain poorly characterised. Methods A multidisciplinary national cross-sectional survey was developed and distributed between November 4–29, 2024, with endorsement from six major Italian scientific societies. The survey included 93 questions addressing availability, technical aspects, clinical use across disease phases, and professional practices. Separate sections were tailored to clinicians and nuclear medicine physicians. Results A total of 238 validated responses were analysed (169 clinicians, 69 nuclear medicine physicians). Nuclear medicine respondents were affiliated mainly with high-volume centres, while clinicians reported greater variability in institutional access. PSMA PET/CT was perceived as insufficiently available by 58% of clinicians at the institutional level, with 36.1% stating that waiting times led to changes in imaging strategy. [ 68 Ga]Ga-PSMA-11 was the preferred tracer among clinicians (57.4%), while nuclear medicine physicians expressed more balanced preferences driven by logistics. Divergent views also emerged regarding the clinical relevance of biodistribution differences. For primary staging, PSMA PET/CT was used by 50% of clinicians for high-risk patients and by 20% for intermediate-risk patients, whereas 87% of nuclear medicine physicians identified PSMA PET/CT as the optimal imaging modality for intermediate-to-high-risk PCa. In cases of discordant imaging findings, multidisciplinary discussion was the preferred strategy for resolution. Conclusion Access to, usage of, and perceptions about PSMA PET/CT differ between clinicians and nuclear medicine physicians, highlighting the need for improved availability and enhanced interdisciplinary coordination.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Imaging
Published
2025-12-17
DOI
https://doi.org/10.1007/s40336-025-00740-w
Citations
1
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
1.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: technical aspects and primary staging setting

Viviana Frantellizzi, Giuseppe Carrieri, Lorenza Marino, Cinzia Iotti et al.
1 citations
Clinical and Translational Imaging
Prostate Cancer Treatment and Research
1.52
article

Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: technical aspects and primary staging setting

Viviana Frantellizzi, Giuseppe Carrieri, Lorenza Marino, Cinzia Iotti, A Marsella, Daria Maccora, Carlo Poti, Piero Mannone, Luca Guerra, Filippo Antonica, Rossella Filice, Emanuela Cagna, Donata Sartori, Marco Raddi, Annarita Perillo, Francesco Pierantoni, E. Garibaldi, V. Parisella, Alessia Reali, Annalisa Quattrocchi, Nerina Denaro, Edoardo Lenci, Giulia Giacoppo, A. Tognoni, Gabriella Arena, Pietro Pepe, Luca Burroni, Stefania Di Girolamo, Martina Fanelli, Claudia Mucciarini, Andrea Romei, Marilena Di Napoli, Domenico Albano, C. Cristini, Linda Cerbone, Stefano Raffa, Vincenzo Iorio, Grazia Lazzari, Giorgio Ivan Russo, Filippo Alongi, Rosalba Rossello, Antonio Galfano, Beatrice Detti, Andrea Sbrana, Giuseppe Chiacchio, Giorgia Timon, Sebastiano Buti, Antonella Fontana, Gabriele Montefusco, Pietro Garlatti, Lorenza Bruschieri, Emanuela Trenti, Maria Isabella Donegani, Marcello Rodari, Cinzia Baiocco, Chiara Carmen Miceli, Alfonso Baldoncini, Micaela Motta, Angelina Cistaro, Luca Urso, Francesco Ceci, Diego Zara, Eugenio Di Giorgio, Guglielmo Mantica, Livia Ruffini, Lorena Picori, Camillo Porta, Giuseppe De Vincentis, Marco Stellato, Simona Borghesi, Pasquale Romano, F. Migliozzi, Pierpaolo Alongi, Paolo Carlini, Rocco Morra, Anna La Salvia, Pier Francesco Ferrucci, Teodoro Sava, Ilaria Zampiva, Daniele Romagnoli, Valeria Pirro, Gianluca Giannarini, Roberto Bortolus, Francesca De Felice, Giorgia Cocco, Eugenio Borsatti, Giulia Rinaldi, Paolo Borghetti, Antonio Ghidini, Domenico Cante, Rosj Gallicchio, Simona Allis, Alberto Buffoli, Marco Maccauro, Virginia Liberini, Massimo Perachino, Andrea Rappazzo, Carlo Messina, Lilia Bardoscia, Mario Pirozzi, Giovanni Busacca, Giustino Silvestro, Konudula Sreenivasa Reddy, Michele Ganovelli, Elisabetta Perrone, Bartolomé Scola, Natale Daniele Calandruccio, Riccardo Laudicella, Isa Bossi Zanetti, Tommaso Carfagno, Marco Maruzzo, Suela Vukcaj, Flavia Serafini, A Platania, Teresa Pironti, Giuseppe Di Lucca, Marco Pisino, Antonio Scarale, Veronica Mollica, Sarah Pia Colangione, Michele Dionese, Elisa Zanardi, Valeria Lami, Giandomenico Roviello, Luciana Di Cristina, Rossella Di Franco, Matteo Bauckneht, Maria Luisa De Rimini, Franco Morelli, Giulio Francolini, Gian Paolo Spinelli, Nadia Cordua, Nadia Pasinetti, Daniela Musio, Alberto Lapini, Rosario Paratore, Francesco Lanfranchi, Vincenza Conteduca, Demetrio Aricò, Greta Celesti, S. Cauda, Rosa Sciuto, Lorenzo Ruggera, Dario Olivieri, Alessandra Cocchi, Stefano Ciccarelli, Emanuele Casciani, Nello Salesi, Corrado Spatola, Michelangelo Bambaci, Daniele Antonio Pizzuto, Sabrina Rossetti, Davide Campobasso, Rocco De Vivo, Nicola Rosa, S. Moroso, Martina Parisi, Alessio Bruni, Alberto Dalla Volta, Andrea Lancia, Liliana Guadagni, Michele Maffezzoli, Sara Elena Rebuzzi, Francesco Cuccia, Sara Pacella, Silvia Angela Debonis, Elena Verzoni, Alessandra Castelluccia, Francesco Chierigo, Francesca Ambrosini, Giovanna Pepe, Ludovico Maria Garau, Donatello Gasparro, Giuseppe Di Lorenzo, Davide Renna, Claudia Piombino, Antonino Battaglia, Alberto Miceli, Giuseppe Procopio, Arnoldo Piccardo, Riziero Esposito Abate, Paola Caroli, Giovanni Vicario, Alessia Ruggiero, Annalisa Bonfiglio, Michele Boero, Angelo Castello, Federica Matteucci, Sergio Bracarda, Salvatore Mussari, Andrea Marchetti, Calogero Casà, Ciro Franzese, Sabrina Genovese, Giovanni Longo, Tiziana Lanzolla, Paolo Andrea Zucali, Alessia Salfi, Giulia Puccini, Giuseppe Tirino, Dario Franzese, Andrea Guttilla, Francesco Marletta, Daniele Galanti, Teresa Del Giudice, Guido Rovera, Claudia Caserta, Cesare Guida, Gaetano Facchini, Federico Paolieri, Marco Krengli, Francesco Atzori, Francesca Rastelli, Glauco Bertello, Mattia Falchetto Osti, Diego De Palma, Valentina Ceriani, Eugenio Miglioranza, Patrizia Farina, Carmelo Caldarella, Priscilla Guglielmo, Sarah Scagliarini, Francesca Zacchi, Luca Vaggelli, Paola Ermacora, Isabella Ricci, Margarita Kirienko, Marianna Montesano, Domenico Barzaghi, Claudio Rossetti, Annalisa Bramati, Roberto Pacelli, Francesco Grillone, Enrico Sammarco, Francesco Guzzi, Alessandro Samuelly, Alberto Signore, Marco Badalamenti, Roberta Di Rocco, Antonio Nicocia, F. Di Gregorio, Stefano Panareo, M. E. Crespo Espindola, Rolando Maria D’Angelillo, Mariella Sorarů, Fernando Muñoz, Francesco Prata, Fabio Matrone, Alessia Cavo, Mariadea Lavalle, Giuseppe Trifirò, Cristina Mantarro, Ettore Di Trapani, Salvatore La Mattina, Maurizio Schifilliti, Giada Pinterpe, Monica Boitano, Michele Caruso, Umberto Basso, Luca Orecchia, Lucia Leccisotti, Elisa Milan, G Brusasco, Valentina Borzillo, Alessandro Crestani, L. Di Gianfrancesco, Alberto De Gobbi, Fabrizio Presicce, Rita Cengarle, Emilio Francesco Giunta, D.P. Pesce, Angelo Naselli, Antonio Vavallo, Matteo Sepulcri, Laura Evangelista, Rocco Mazza, Giuseppe Rubini, Angelina Filice, Lucia Barsacchi, Tommaso Brancato, Claudio Vitale, Nicola Frega, Edoardo Cisero, Francesca Montagnani, Luca Antonelli, Daniele Santini, Tania Di Raimondo, Giorgia Maria Granese, Cosimo Ciotta, Federico Garrou, Chiara Lorubbio, Gabriele Bignante, Salvatore Carrozza, Giuseppe Candita, A. D'Arienzo, Claudia Mosillo, Andrea Mari, Alessio Rizzo, Federico Colombo, Andrea Bianchi, Marco Roscigno, Anna Giulia Nappi, Riccardo Schiavina, Francesco Clemente, Andrea Alberti, M. Ferro, Andrea Conti, Giuseppe Giovinazzo, Mario Savino, Daniela Sanna, Francesca Maggio, Michele Pennisi, Fabio Ferrarese, Andrea Zivi, Giuseppe Fornarini, Nicolò Borsellino, Domenico Germano, Barbara Turi, Gaia Mango, Antonio Vento, Marco Andrea Signor, Giovambattista Roda’, Michele Bruno, Valentina Baldazzi, Luca Sofia, Giuseppe Dinoi, Antonio Spinoso, Antonio Giorgio, Fabio Calabrò, Letizia Galeasso, Oriana Calisto, Redona Tafili, Flaminia Vocaturo, Angelo Andrea Chirillo, Lucia Fraino, Gianluca Frusciante, Elisa Peci, Roberto Sabatina, Liboria Maria Grazia Travagliato, Gian Franco Bardino, Lucio Carozzi
article en
1 citations

Abstract

Abstract Background Prostate-specific membrane antigen PET/CT (PSMA PET/CT) has become a cornerstone in the imaging of prostate cancer (PCa), supported by growing evidence and international guideline endorsements. However, real-world adoption and clinical integration of PSMA PET/CT in Italy remain poorly characterised. Methods A multidisciplinary national cross-sectional survey was developed and distributed between November 4–29, 2024, with endorsement from six major Italian scientific societies. The survey included 93 questions addressing availability, technical aspects, clinical use across disease phases, and professional practices. Separate sections were tailored to clinicians and nuclear medicine physicians. Results A total of 238 validated responses were analysed (169 clinicians, 69 nuclear medicine physicians). Nuclear medicine respondents were affiliated mainly with high-volume centres, while clinicians reported greater variability in institutional access. PSMA PET/CT was perceived as insufficiently available by 58% of clinicians at the institutional level, with 36.1% stating that waiting times led to changes in imaging strategy. [ 68 Ga]Ga-PSMA-11 was the preferred tracer among clinicians (57.4%), while nuclear medicine physicians expressed more balanced preferences driven by logistics. Divergent views also emerged regarding the clinical relevance of biodistribution differences. For primary staging, PSMA PET/CT was used by 50% of clinicians for high-risk patients and by 20% for intermediate-risk patients, whereas 87% of nuclear medicine physicians identified PSMA PET/CT as the optimal imaging modality for intermediate-to-high-risk PCa. In cases of discordant imaging findings, multidisciplinary discussion was the preferred strategy for resolution. Conclusion Access to, usage of, and perceptions about PSMA PET/CT differ between clinicians and nuclear medicine physicians, highlighting the need for improved availability and enhanced interdisciplinary coordination.

Clinical and Translational ImagingVol. 14(2)
University of Rome Tor Vergata (IT), Marche Polytechnic University (IT), Humanitas University (IT), University of Padua (IT), Ospedale Santa Chiara (IT), Azienda Sanitaria Unità Locale di Reggio Emilia (IT), Istituto Oncologico Veneto (IT), Azienda Ospedaliero-Universitaria Careggi (IT), Azienda USL di Bologna (IT), Azienda Ospedaliera S.Maria (IT), Ospedale Monaldi (IT), Ospedale Policlinico San Martino (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Azienda Usl Toscana Centro (IT), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), IRCCS Humanitas Research Hospital (IT), University of Florence (IT), University of Genoa (IT)
Associazione Italiana di Oncologia Medica, Università degli Studi di Genova
Openalex Percentile: Top 12%
Prostate Cancer Treatment and Research
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.